You are here

Article Text

Article menu
Download PDFPDF
Industry watch
Electronic nicotine delivery systems in the hands of Hollywood
  1. Rachel A Grana1,2,
  2. Stanton A Glantz1,2,3,
  3. Pamela M Ling1,2,4
  1. 1Department of Medicine, Center for Tobacco Control Research and Education, University of California, San Francisco, California, USA
  2. 2Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, California, USA
  3. 3Division of Cardiology, University of California, San Francisco, California, USA
  4. 4Division of General Internal Medicine, University of California, San Francisco, California, USA
  1. Correspondence to Pamela M Ling, Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 9414‐31390, USA; pling{at}medicine.ucsf.edu

https://doi.org/10.1136/tc.2011.043778

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Electronic nicotine delivery systems (ENDS) (colloquially called electronic cigarettes or e-cigarettes) have been advertised increasingly aggressively in the USA and other countries in the past 4–5 years.1 These cigarette-shaped battery-powered devices heat a liquid solution containing various concentrations of nicotine, creating a vapour for inhalation. In recent months, ENDS have started to appear in popular entertainment through movies, television shows and on-air advocacy by Hollywood celebrities. On 7 January 2011, the Los Angeles Times noted that ENDS were used by movie star Johnny Depp in the recently released film The Tourist.2 On 27 September 2010, star Katherine Heigl appeared on ‘The Late Show with David Lettermen’, where …

    View Full Text

    Footnotes

    • Funding National Cancer Institute grant nos: R25-CA113710, R01-CA141661 and R01-CA87472.

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.